LMR Partners’s Treace Medical Concepts TMCI Stock Holding History

LMR Partners’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-43,171	Closed	-$550K	–	1310
2023 Q4	$550K	Buy	+43,171	New	+$436K	0.01%	636

Other funds holding TMCI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

LMR Partners's TMCI Position: Q1 2024 in Review

LMR Partners sold out of Treace Medical Concepts (TMCI) in Q1 2024, closing a stake of 43,171 shares — an estimated $550K sold.

LMR Partners first reported a position in TMCI in Q4 2023 and held it in 1 quarter. The position peaked at $550K in Q4 2023. 132 funds tracked by Wall St. Rank hold TMCI as of Q1 2024.

LMR Partners reported no remaining Treace Medical Concepts position as of Q1 2024 after selling out during the quarter.
LMR Partners sold 43,171 Treace Medical Concepts shares in Q1 2024, an estimated $550K.
LMR Partners first reported a position in Treace Medical Concepts in Q4 2023 and held it in 1 quarter.
LMR Partners's Treace Medical Concepts position peaked at $550K in Q4 2023.
132 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2024.

Based on LMR Partners's 13F filing for Q1 2024, filed 15 May 2024.